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ABSTRACT 
 
Regulation of Colonocyte Apoptosis by Bcl-2:  
Influence of Chemotherapeutic Dietary Agents (April 2008) 
 
Harmony Faith Turk 
Department of Nutrition and Food Science 
Texas A&M University 
 
Research Advisor: Dr. Robert S. Chapkin 
Department of Nutrition and Food Science 
 
This study intends to elucidate a mechanism of cancer prevention by certain nutrients. 
The health benefits of n-3 polyunsaturated fatty acids, e.g., docosahexaenoic acid 
(DHA), and fiber are well documented. It has been previously documented that DHA 
and butyrate, a fiber by-product, work synergistically to prevent colorectal cancer by 
increasing cell death (apoptosis). The resulting increase in apoptosis could be caused in 
part by down-regulation of the anti-apoptotic protein bcl-2. This study aimed to 
determine the correlation of bcl-2 and the apoptotic effects of butyrate and DHA. 
Immortalized mouse colonocytes were pre-treated with DHA, transfected with human 
bcl-2 cDNA to overexpress full length bcl-2, and then co-treated butyrate. Apoptosis 
was measured using an enzyme-linked immunosorbent assay (ELISA), and western 
immunoblot was used to quantify bcl-2 levels. Apoptosis was significantly different 
(P<0.05) in DHA and butyrate treated cells depending on whether or not cultures were 
transfected with bcl-2.  The DHA and butyrate treated cells transfected with bcl-2 
contained significantly fewer apoptotic cells compared to untransfected DHA and 
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butyrate treated cells.   These data suggest that DHA and butyrate induce apoptosis in 
part by decreasing bcl-2 expression. 
  
  v 
ACKNOWLEDGMENTS 
 
I would like to thank my research advisor, Dr. Robert S. Chapkin, for guiding me 
through this process and assisting me in every way that he could.  I would also like to 
thank Dr. Satya Kolar for teaching me numerous techniques and always helping me 
when I needed it.  I would like to thank Dr. Yang-Yi Fan for her assistance and being 
tough on me when I needed it.  I would also like to thank everyone else in the lab, 
especially Dr. Laurie Davidson and Evelyn Callaway, for pointing me in the right 
direction and always offering support and advice. 
 
 
  vi 
TABLE OF CONTENTS 
  Page 
ABSTRACT ....................................................................................................................... iii 
ACKNOWLEDGMENTS ................................................................................................... v 
TABLE OF CONTENTS ................................................................................................... vi 
LIST OF FIGURES .......................................................................................................... viii 
CHAPTER 
 I INTRODUCTION ....................................................................................... 1 
              Colon cancer .................................................................................... 1 
   Apoptosis ......................................................................................... 1 
   Chemotherapeutic nutrients ............................................................. 2 
   Bcl-2 ................................................................................................ 3 
   Purpose ............................................................................................ 4 
 II MATERIALS AND METHODS ................................................................ 5 
   Materials .......................................................................................... 5 
   Plasmid sequencing ......................................................................... 6 
   Cell culture ...................................................................................... 6 
   Transfection ..................................................................................... 7 
   Fluorescent imaging ........................................................................ 7 
   Apoptosis assay ............................................................................... 8 
 III RESULTS .................................................................................................... 9 
   Sequencing ...................................................................................... 9 
   Fluorescence microscopy .............................................................. 10 
   Apoptosis ....................................................................................... 11 
 IV DISCUSSION AND CONCLUSIONS ..................................................... 14 
REFERENCES .................................................................................................................. 16 
APPENDIX A ................................................................................................................... 18 
APPENDIX B ................................................................................................................... 19 
  vii 
APPENDIX C ................................................................................................................... 22 
APPENDIX D ................................................................................................................... 25 
APPENDIX E .................................................................................................................... 28 
CONTACT INFORMATION ........................................................................................... 29 
 
  viii 
LIST OF FIGURES 
 
FIGURE Page 
 1 Sequence of full-length human bcl-2 ..................................................................... 9 
 2 Bcl-2 expression as shown by fluorescence microscopy ..................................... 11 
 3 Apoptotic index of treatments as measured by ELISA assay .............................. 12 
 4 Putative mechanism by which overexpression of bcl-2 modulates DHA and 
butyrate-induced apoptosis in colonocytes .......................................................... 15 
 
1 
CHAPTER I 
INTRODUCTION 
 
Colon cancer 
Colon cancer is one of the leading causes of death from cancer in almost all developed 
countries.1 Colon cancer is thought to be affected by numerous environmental aspects, 
and it is estimated that up to 70% of colorectal cancers can be prevented by moderate 
changes in lifestyle and eating habits.2 Since the colon is a key aspect of the digestive 
tract, nutrients that are consumed can regulate homeostatic mechanisms within the colon.  
Therefore, it is likely that colon cancer is heavily influenced by dietary constituents.  
Overall, certain nutrients play an important role in regulating carcinogenesis.  
 
Apoptosis 
Carcinogenesis is a complex process that perturbs the homeostasis of intestinal epithelial 
cell proliferation, differentiation, and programmed cell death.3 An important aspect of 
preventing carcinogenesis is prohibiting the perpetuation of DNA damaged cells through 
processes of programmed cell death.  One particular type of programmed cell death is 
apoptosis.  Apoptosis is utilized to remove cells that are in excess, old, or damaged  
_______________ 
This thesis follows the style of Cancer. 
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beyond repair, and it is critical that proliferation and apoptosis are balanced in order to 
maintain the steady-state number of cells in the colon.4 Apoptosis results from a series of 
reactions that signal for the cell to die.  When apoptosis is impeded, damaged cells are 
no longer removed.  Apoptosis is crucial in preventing carcinogenesis because it 
eliminates unwanted and damaged cells that could potentially become tumorigenic.5  
Several different factors exist that have an effect on the overall regulation of apoptosis.   
 
Chemotherapeutic nutrients  
Dietary fatty acids and fiber are two highly investigated regulators of colon 
carcinogenesis.  Epidemiological studies have shown that there is an inverse relationship 
between high intake of fish and colorectal cancer.6 Substantial evidence demonstrates 
that n-3 polyunsaturated fatty acids (PUFA), such as docosahexaenoic acid (DHA) and 
eicosapentaenoic acid (EPA), are chemopreventative agents in fish oil that protect 
against colon tumorigenesis.  The combination of n-3 PUFA with certain fiber sources is 
potentially more chemoprotective than n-3 PUFA alone.  Our lab has shown that feeding 
rats a diet rich in n-3 PUFA (fish oil) with pectin as a fiber source results in more than 
twice the apoptotic index in the colon compared with diets high in n-6 (corn oil) and n-9 
(olive oil) dietary lipids.7 It has recently been shown that the bioactive compound in 
pectin is butyrate, a four carbon fatty acid fermentation product of pectin.8 Furthermore, 
a significant increase in colonocyte apoptosis was observed when rats were fed a diet 
containing fish oil and butyrate pellets for targeted release in the colon.8  Subsequently, 
our lab determined in vitro that DHA and butyrate work synergistically to enhance 
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apoptosis by up to 43% in colonocyte cultures compared with butyrate alone, indicating 
that DHA is a bioactive component of fish oil.9  Furthermore, our lab has shown that 
DHA and butyrate synergize via a Ca2+-mediated intrinsic mitochondrial pathway to 
induce apoptosis.9  Overall, n-3 PUFA and butyrate are very important chemoprotective 
nutrients. 
 
Bcl-2 
Bcl-2 is a 26-kDa protein which has been found to be closely related to apoptosis.  It has 
been shown to be mainly localized in the mitochondrial membrane, nuclear membrane, 
and the endoplasmic reticulum.10 Bcl-2 is expressed in cells that are rapidly dividing and 
differentiating, and it has also been shown that bcl-2 has the ability to inhibit apoptosis 
by conserving the integrity of the mitochondrial matrix so that pro-apoptotic molecules 
cannot escape from the mitochondria.11 Bcl-2 is one of the most important regulators of 
both spontaneous and damage-induced apoptosis.12 By inhibiting programmed cell 
death, bcl-2 plays a critical role in the process of tumorigenesis.  High levels of bcl-2 are 
capable of keeping cells alive after tumorigenic mutations have been incurred, and 
overexpression of bcl-2 has been linked to many types of human cancer, including 
colorectal cancer.11 Bcl-2 levels have been shown to be affected by diet.  Our lab has 
shown that bcl-2 levels in rats fed fish oil containing diets with pectin as a fiber source 
are lower compared to rats fed a corn oil based diet.13 In the same experiment, bcl-2 
levels were shown to be negatively correlated to apoptosis.  These results suggest that 
the downregulation of bcl-2 could be responsible for the increase in apoptosis.   
  4 
Purpose 
The purpose of this project was to determine if the ability of DHA and butyrate to induce 
apoptosis is in the result of a decrease in colonic bcl-2 levels.  The goal was to measure 
the level of apoptosis in a mouse colonocyte line (YAMC) after treating cells with 
bioactive nutrients and overexpressing bcl-2.  Changes in apoptosis resulting from a 
treatment of DHA (active component in fish oil) and butyrate (active component in 
pectin) were compared with other treatments.  Overall, we determined the change in 
apoptosis that results from a diet high in n-3 PUFA and butyrate is due in part to 
decreased levels of bcl-2.   
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CHAPTER II 
MATERIALS AND METHODS 
 
Materials 
RPMI 1640 and Hanks’ balanced salt solution (HBSS) were purchased from Mediatech 
(Herndon, VA).  Dulbeco’s phosphate buffered saline (PBS), glutamax, and interferon-γ 
were purchased from Gibco BRL (Grand Island, NY).  Fetal bovine serum (FBS) was 
obtained from Hyclone (Logan, UT).  Insulin, transferrin, selenium without linoleic acid 
were purchased from Collaborative Biomedical Products (Bedford, MA).  Fatty acids 
were purchased from NuChek (Elysian, MN).  Butyrate was obtained from Thermo 
Fisher Scientific, Inc. (Waltham, MA).  NaN3 was received from Sigma-Aldrich Co. (St. 
Louis, MO).  Rabbit Bcl-2 polyclonal antibody was purchased from Assay Designs (Ann 
Arbor, MI).  Alexa 568 goat anti-rabbit IgG and ProLong Antifade Kit were purchased 
from Molecular Probe (Eugene, OR).  Nucleofector device II and nucleofector kit L 
were obtained from Amaxa (Gaithersburg, MD).  Lab-Tek II 2-well glass chamber slides 
were purchased from Nalge Nunc, Inc. (Rochester, NY).  Cell detection ELISA kit and 
fatty acid free bovine serum albumin (BSA) was from Roche Applied Science 
(Indianapolis, IN).  ABI PRISM® 3100 Genetic Analyzer was purchased from Applied 
Biosystems (Foster City, CA). 
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Plasmid sequencing 
Three human bcl-2 constructs were received from Dr. Maria Hoyer-Hansen, Danish 
Cancer Institute.14 The plasmids had been cloned into the episomal vector pCEP4 from 
Invitrogen. One plasmid encoded full-length human bcl-2.  Another plasmid contained a 
35 amino acid sequence of the endoplasmic reticulum (ER)-specific isoform of rat 
hepatic cytochrome b5 which replaced the 21 amino acid carboxy-terminus of bcl-2 to 
target bcl-2 predominantly to the ER.15 The last construct also contained a 27 amino acid 
insert from the protein Act-A from Listeria monocytogenes to target bcl-2 to the 
endoplasmic reticulum. 15 All three constructs were sequenced using an ABI PRISM® 
3100 Genetic Analyzer.  Only the full-length bcl-2 was used in this experiment.   
 
Cell culture 
YAMC cells, immortalized mouse colonocytes, were originally obtained from R. H. 
Whitehead, Ludwig Cancer Institute (Melbourne, Australia).  Cells were cultured under 
permissive conditions, 33 oC and five percent atmospheric CO2 with interferon-γ, as 
previously described.16, 17 Bovine serum albumin (BSA) complexed fatty acid was added 
to cultures 24 hours after cell plating as previously described.17 Select cultures were 
treated with BSA-complexed DHA (22:6, n-3) (50 µM) for 72 hours.  Protocol for cell 
culture techniques can be found in Appendix A. 
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Transfection 
Forty-eight hours after seeding (24 hours after DHA treatment), cells underwent 
transfection using Amaxa Nucleofector Device II and Amaxa Nucleofector Kit L.  The 
cells were transfected with full length human bcl-2 plasmid.  YAMC cells were 
transfected with 0 or 2 µg of bcl-2 DNA for the purpose of overexpressing bcl-2.  
Program A-020 was used on the nucleofector device for the transfection.  After 
transfection, cells were seeded onto 2-chambered cover glass slides at a density of 2.0 x 
105 for further analysis.  For apoptosis assays, cells were seeded into 6-well plates at a 
density of 1.2 x 105.  Select cultures were initially treated with BSA-complexed DHA 
for 48 hours.  Cells that were treated with DHA were co-treated with butyrate (5 mM) in 
RPMI media for the final 24 hours of fatty acid pre-treatment.  Protocol for transfection 
techniques can be found in Appendix B. 
 
Fluorescent imaging 
Overexpression of bcl-2 was measured by immunohistochemistry.  Cells were plated 
onto 2-chambered cover glass slides.  After 48 hours, cells were fixed with 4% 
paraformaldehyde for twenty minutes and incubated at 4oC overnight in blocking 
solution (1%BSA/0.1%NaN3 in PBS).  Next, cells were incubated with rabbit anti-bcl-2 
[20 µg/µL] for one hour.  Subsequently, cells were incubated with Alexa 568 goat anti-
rabbit IgG [10 µg/µL] as a secondary antibody for one hour.  Fluorescence was viewed 
with TE 300 Nikon Eclipse fluorescence microscope.  Cells were excited at 595-605 nm 
and fluorescence emission was collected at 620 nm. Images were taken with an inverted 
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with a digital Cool SNAPEX Monochrome camera from Photometrics with 12 bits  @ 
20 mghz, a DEI-750D 3-chip Optronics color camera.   Protocol for 
immunohistochemistry can be found in Appendix C. 
 
Apoptosis assay  
Apoptosis was measured using cellular fragmentation enzyme linked immuno-sorbent 
assay (ELISA) (Roche) as previously described.17  Apoptosis in floating and adherent 
cells was measured 24 hours after adding the butyrate and BSA-complexed DHA co-
treatment.  Apoptotic index was calculated by dividing 100 times the absorbance 
calculated by the ELISA by the number of adherent cells.  Techniques for ELISA can be 
found in Appendix D. 
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CHAPTER III 
RESULTS 
 
Sequencing 
The full-length bcl-2 was sequenced.  Basic Local Alignment Search Tool (BLAST) was 
used to calculate homology.  The full-length bcl-2 had 99% homology with the B-cell 
lymphoma protein 2 (bcl-2) alpha isoform from Homo sapiens. The sequence is listed in 
Figure 1.  The sequences for the other two constructs are located in Appendix E. 
 
A 
 
ATGGCGCACGCTGGGAGAACAGGGTACGATAACCGGGAGATAGTGATGAAGTACATCCAT  
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
ATGGCGCACGCTGGGAGAACAGGGTACGATAACCGGGAGATAGTGATGAAGTACATCCAT   
 
TATAAGCTGTCGCAGAGGGGCTACGAGTGGGATGCGGGAGATGTGGGCGCCGCGCCCCCG 
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
TATAAGCTGTCGCAGAGGGGCTACGAGTGGGATGCGGGAGATGTGGGCGCCGCGCCCCCG 
 
GGGGCCGCCCCCGCACCGGGCATCTTCTCCTCCCAGCCCGGGCACACGCCCCATCCAGCC  
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
GGGGCCGCCCCCGCACCGGGCATCTTCTCCTCCCAGCCCGGGCACACGCCCCATCCAGCC 
 
GCATCCCGGGACCCGGTCGCCAGGACCTCGCCACTGCAGACCCCGGCTGCCCCCGGCGCC 
|||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||| 
GCATCCCGGGACCCGGTCGCCAGGACCTCGCCGCTGCAGACCCCGGCTGCCCCCGGCGCC 
 
GCCGCGGGGCCTGCGCTCAGCCCGGTGCCACCTGTGGTCCACCTGACCCTCCGCCAGGCC  
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
GCCGCGGGGCCTGCGCTCAGCCCGGTGCCACCTGTGGTCCACCTGACCCTCCGCCAGGCC 
 
 
 
FIGURE 1.  Sequence of full-length human bcl-2.  The aligned sequence (A) shows that the plasmid 
matched 705 of 720 nucloetides; the top line is the plasmid and the bottom line is the given bcl-2 alpha 
isoform from BLAST. The derived amino acid sequence (B) shows that two out of 239 amino acids did 
not correlate to the amino acid sequence given by BLAST.  Differences are highlighted in red. 
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GGCGACGACTTCTCCCGCCGCTACCGCCGCGACTTCGCCGAGATGTCCAGCCAGCTGCAC  
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
GGCGACGACTTCTCCCGCCGCTACCGCCGCGACTTCGCCGAGATGTCCAGCCAGCTGCAC 
 
CTGACGCCCTTCACCGCGCGGGGACGCTTTGCCACGGTGGTGGAGGAGCTCTTCAGGGAC  
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CTGACGCCCTTCACCGCGCGGGGACGCTTTGCCACGGTGGTGGAGGAGCTCTTCAGGGAC 
 
GGGGTGAACTGGGGGAGGATTGTGGCCTTCTTTGAGTTCGGTGGGGTCATATGTGTGGAG  
|||||||||||||||||||||||||||||||||||||||||||||||||| ||||||||| 
GGGGTGAACTGGGGGAGGATTGTGGCCTTCTTTGAGTTCGGTGGGGTCATGTGTGTGGAG 
 
AGCGTCAACCGGGAGATGTCGCCCCTGGTGGACAACATCGCCCTGTGGATGACTGAGTAC  
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
AGCGTCAACCGGGAGATGTCGCCCCTGGTGGACAACATCGCCCTGTGGATGACTGAGTAC 
 
CTGAACCGGCACCTGCACACCTGGATCCAGGATAACGGAGGCTGGGATGCCTTTGTGGAG 
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
CTGAACCGGCACCTGCACACCTGGATCCAGGATAACGGAGGCTGGGATGCCTTTGTGGAA 
 
CTCTACGGCCCCAGCATGCGGCCTCTGTTTGATTTCTCCTGGCTGTCTCTTAAGACTCTG   
|| ||||||||||||||||||||||||||||||||||||||||||||||| |||||||||   
CTGTACGGCCCCAGCATGCGGCCTCTGTTTGATTTCTCCTGGCTGTCTCTGAAGACTCTG   
 
CTCTCGCTAG-CACTAGTGGGAGCATGCATCACCCTGGGTGCCTATCTGTCCCACAAGTGA   
|||  | | | | || |||||||| ||||||||||||||||||||||||  |||||||||| 
CTCA-GTTTGGCCCTGGTGGGAGCTTGCATCACCCTGGGTGCCTATCTGGGCCACAAGTGA 
 
B 
 
FIGURE 1, Continued. 
 
 
 
Fluorescence microscopy 
Fluorescence microscopy was used to examine transfection efficiency.  An antibody for 
bcl-2 was used to detect bcl-2 expression 24 hours following transfection.  As shown by 
Figure 2, the cells that were transfected with bcl-2 exhibited much more fluorescence.  
MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPG
HTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYR
RDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVICVESVNR
EMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSL
KTLLSLALVGACITLGAYLSHK  
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Mock 
Transfected
Transfected
With 2 μg Bcl-2
 
FIGURE 2. Bcl-2 expression as shown by fluorescence microscopy. YAMC cells were transfected with 
either an empty vector or a vector containing bcl-2.  YAMC cells were subsequently cultured for 48 h.  
Cells were then fixed and treated with rabbit anti-bcl-2 for 1 h followed by Alexa 568 conjugated goat 
anti-rabbit IgG for 1 h.  Bcl-2 levels were elevated 48 h following transfection (lower panel).  
 
These data indicate that bcl-2 was overexpressed in the transfected cells.  Approximately 
75% (76% + 0.075; n=3) of the transfected cells showed significantly enhanced bcl-2 
levels. 
 
Apoptosis 
Intranucleosomal degradation of genomic DNA, a biomarker for apoptosis, was detected 
by an ELISA assay.  As shown in Figure 3, the apoptotic index was lowest in the mock 
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transfected control(C) and bcl-2 transfected control (CT) cells, i.e., no DHA or butyrate 
added.   
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FIGURE 3. Apoptotic index of treatments as measured by ELISA assay.  C, mock transfected control; 
CT, bcl-2 transfected control; DB, mock transfected and treated with DHA and butyrate; DBT, bcl-2 
transfected and treated with DHA and butyrate. n=8-12 separate wells for each group from 2 separate 
experiments. Statistical significance was measured using Fisher’s Protected Least Significant Difference 
test (LSD). P<0.05. 
 
 
 
Mock transfected cells incubated in the presence of DHA and butyrate (DB) exhibited 
the highest apoptotic index.  Apoptotic index for control (C) was set at 100%, and all 
other groups were compared to C. The apoptotic index for mock transfected cultures 
treated with DHA and butyrate increased approximately three-fold relative to control 
(DB vs. C).  Bcl-2 transfected cells treated with DHA and butyrate (DBT) exhibited 
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significantly decreased (~ 50%) apoptotic index, compared to DB.  In comparison, DBT 
had almost two-fold higher levels of apoptosis compared to both C and CT.   
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CHAPTER IV 
DISCUSSION AND CONCLUSIONS 
 
DHA and butyrate are well known chemopreventative agents that promote apoptosis. 
 Bcl-2 is a protein that is capable of inhibiting apoptosis.  When colonocytes are cultured 
in the presence of DHA and butyrate, bcl-2 levels are reduced and apoptosis is increased. 
We showed in this study for the first time that the ectopic expression of bcl-2 can 
partially block the induction of apoptosis in colonocytes treated with DHA and butyrate. 
Figure 4 illustrates how overexpressing bcl-2 can block the effects of DHA and 
butyrate. Even though overexpression of bcl-2 in DHA and butyrate treated cells 
significantly decreased apoptosis compared to mock transfected DHA and butyrate cells, 
overexpression of bcl-2 alone did not bring the levels of apoptosis back to control.  This 
suggests that there may be multiple apoptotic pathways induced by DHA and butyrate. 
 By determining the mechanisms employed by these chemotherapeutic nutrients, we 
hope to learn how to optimally use these nutrients to reduce the abundance of cancers, 
e.g., colorectal cancer. 
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FIGURE 4. Putative mechanism by which overexpression of bcl-2 modulates DHA and butyrate-induced 
apoptosis in colonocytes.  The left panel shows how DHA and butyrate treatment suppresses bcl-2 levels 
and therefore promotes apoptosis. The right panel illustrates how forced overexpression of bcl-2 partially 
blocks cell death.  
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APPENDIX A 
PROTOCOL: CELL LINE SEEDING AND FEEDING 
 
Purpose: To seed cells for apoptosis assay  
 
Materials: 
• Complete RPMI 1640 media 
• γ-IFN (Gibco BRL#13284-021) 
• HBSS 
• Trypsin 
• 2 T-175 flask 
• 50 mL conical tube 
• Plastic pipettes 
• Glass pipettes 
 
Procedure: 
 
1.  Sterilize the hood. 
2.  Warm complete RPMI 1640 media to room temperature. 
3.  Aliquot 20 mL of media into a 50 mL conical tube in which to spin down the cells. 
4.  Make up 50 mL of complete media with 5 µL γ-IFN in two 50 mL conical tubes. 
5.  Aspirate media from flask.  Wash with 15 mL HBSS.  Aspirate HBSS. 
6.  Add 10 mL trypsin and incubate at 37oC for 3 minutes. 
7.  Add media into the flask to stop the trypsinization.  Put trypsinized cells into the 
conical tube to spin down cells. 
8.  Centrifuge the cells in the tube at 200 x g (1096 rpm) in the tabletop centrifuge for 5 
min at 6 Acc./Dcc. 
9.  Open the two T-175 flasks under the hood using sterile techniques  
10.  Add approximately 22 mL of complete media (with γ-IFN) from the 50 mL conical 
tube into each flask. 
11.  After completion of the spin, aspirate the supernatant to remove the media from the 
cells (be careful not to disturb the pellet at the bottom). 
12.  Resuspend the pellet in 5 mL of complete media from the 50 mL conical tube. 
13.  Count the cells and seed approximately 8.0 x 105 cells into two flasks. 
Need approximately 1.5 x 106 cells for each transfection (2 transfections per flask so             
need 3.0 x 106 cells per flask on day 2). 
       3.0 x 106/2 = 1.5 x 106/2 = 7.5 x 105 
13.  Add the resuspended cells to the T-175 flask and rotate it gently to distribute the 
cells evenly. 
14.  Label the flask—specify the cell type, passage number, initials, and date. 
15.  Incubate the flask at 33oC under 5% CO2 atmospheric pressure. 
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APPENDIX B 
PROTOCOL: TRANSFECT YAMC CELLS WITH BCL-2 
CONTAINING PLASMIDS 
 
Purpose: To transfect cells with bcl-2 in order to overexpress bcl-2. 
 
Materials: 
Amaxa Nucleofector Device II 
 Amaxa Nucleofector Kit L (cat# VCA-1005) 
 100 µL Nucleofector solution L (per reaction-total of 1mL) 
 2-Lab-Tek II 2-well glass chamber slide (Nalge, cat# 154461) 
Glass pipettes  
Complete Culture Medium (RPMI 1640 (cat #15-040-CV) with FBS, ITS, and 
Glutamax-1) 
 γ-IFN (Gibco BRL#13284-021) 
PBS (Gibco, cat#14190) 
 Trypsin ( cat # 25300054) 
 10 µL and 200 µL pipettes and tips 
 0.6 µL Eppendorf tubes (one per reaction) 
 15 mL conical tubes 
 1-2 x 106 YAMC cells (per reaction) 
Bcl-2 DNA (2 µg (4.52 µL) wild type Bcl-2 per reaction with DNA)  
4 6-well plates 
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Procedure: 
1.  From the Nucleofector kit L, mix the Supplement to Nucleofector solution L at 
the ratio of 2:9 (v/v)-(100 µL supplement and 450 µL of solution L).  Mix gently.  
(It is stable for 3 months at 4°C.) This is now the Nucleofector solution (SN). 
2. Pre-warm SN to room temp.   Pre-warm 25 mL complete culture medium (with 
γ-IFN) (12.5 mL in 2-15 mL conicals) and 25 mL of FA-BSA-Media (12.5 mL in 
2-15 mL conicals) at 33°C. 
 12.5 mL (50 µM) / 2.5 mM = .25 mL = 250 µL FA in 12.5 mL media 
3. Aspirate old media from the flasks and wash cells with PBS (about 20 mL for a 
T-175). 
4. Harvest cells with trypsin (about 10 mL).  Incubate at 37°C for about 5 minutes 
then stop the reaction by adding 20 mL of complete RPMI medium to the flask 
then putting the entire mixture into a 50 mL conical tube.  
5. Take an aliquot of cell suspension for cell counting and count to determine the 
concentration (will need approximately 3.0 x 106 cells per tube).  Some of the 
cells can be thrown out at this point if the concentration is too high. 
6. Centrifuge at 90 x g for 10 min at room temperature.   
7. Select program “A-020” from the Nucleofector device II.  
8. Remove pre-warmed media from the incubator. 
9. Use the special long pipette (provided in the kit) to suck up 500 µL (to the line 
above the ball area of the pipette) of pre-warm complete media or FA-BSA-
Complete Media (depending on which treatment) from one of the 15 mL conical 
tubes.  Keep it in a sterile place. 
10. After centrifugation, resuspend the cell pellet with SN at the final concentration 
of 1.6 x 106/100 µL SN.  (Avoid storing the cells in SN for more than 15 min, as 
this will reduce cell viability and transfection efficiency).   
11. Mix 100 µL of cell suspension with either 4.52 µL 1xTE (0 µg DNA) or 4.52 µL 
of wild type Bcl-2 (2 µg) DNA in a sterile 0.6 mL eppy-tube. 
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12. Transfer 100 µL of the cell/DNA mixture to an Amaxa certified cuvette 
(provided in the kit).  Make sure that the sample covers the bottom of the cuvette 
and avoid air bubbles.  Close the cuvette with the blue cap. 
14. Insert the cuvette into the cuvette holder on the Nucleofector device and press the 
“X” button to start the program.   
15. Remove the cuvette from the device immediately after it is finished and add the 
500 µL medium from the long pipette into the cuvette.  Then immediately 
transfer the entire sample to pre-warm media (or FA treatment) in the conical 
tube from which the 500 µL was taken to dilute to the appropriate concentration 
(approximately 120,000 cells per mL). 
 1.5 x 106  cells / 12.5 mL = 1.2 x 105 cells/mL 
16. Transfer 1 mL of cells into each well on the 6-well plate.**Be sure to add the 
cells drop wisely and distribute evenly.** 
17. Also, transfer 1 mL from each control (no FA treatment) into a well on a 2-well 
glass chamber slide for fluorescent microscopy. 
17. Incubate at 33oC for approximately 24 hours.   
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 APPENDIX C 
PROTOCOL: BCL-2 WT IMAGING IN YAMC CELLS  
 
Purpose:  To image Bcl-2 WT that has been overexpressed in YAMC cells  
Materials: 
 Rabbit anti Bcl-2 (Stressgen, cat# AAS-070E) Ref. Hoyer-Hansen M., et. al. 
2007, Mol Cell, Vol 25, No. 2, p.193-205. 
Alexa 568 goat anti-rabbit IgG(H+L), [2 mg/mL] (Molecular Probe, cat# A-
 11036) 
 ProLong Antifade Kit (Molecular Probe, cat# P-7481)  
 Coverglass (No. 1, 22 x 50 mm, Corning) 
 Fresh 4% PFA in PBS (dilute from 20% PFA, EMS#15713-S) 
 Lab-Tek II 2-well glass chamber slide (Nalge, cat# 154461) 
 
Procedure: (n=2) 
Approximately 24 hours after transfection: 
1. Wash cells (on the chamber slide) with PBS 3x 
2.  Immediately fix in Fresh 4% paraformaldehyde in PBS for 20 min at RT.   
3. Rinse samples with PBS 2x  
4. Incubate cells with 10 mM glycine in PBS for 10 min at RT (to quench the aldehyde 
groups)   
5. Wash coverglass with PBS 2x  
6. Permeabilize cells in PBS/0.2% Triton X-100 for 5 min at RT 
7. Wash with PBS 3x.  
8. Incubate cells in Blocking solution (1%BSA/0.1%NaN3 in PBS) at 4°C overnight 
9. Wash coverglass with PBS 3 x. 
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(Dilute AB in Blocking solution to make 20 µg/mL) 
 
(For 1 well): 
10. (Bcl-2) 1°AB mix:  
20 µg/mL: 4 µL of α−Βcl-2 [stock 1 mg/mL] (1:20 dil) +  196 µL buffer   
Incubate all cells with 200 µL AB/well, incubate at room temp for 1 hr (Protect 
from light)   
11. After 1 h incubation, wash chamber slide with PBS 3 x, and the last wash with            
blocking solution. 
2° AB: 1 µL of Alexa 568 goat anti-rabbit IgG [stock 2 mg/mL] (1:200 
dil) + 199 µL buffer 
12. Incubate cells with 2° AB Alexa 568 goat anti-rabbit IgG [10µg/mL] 200 µL 
AB/well at RT for 1 hr at a humidity chamber.   
13. Prepare the ProLong medium and labeling slides during the 1 hr incubation 
14. Mix 1 mL of ProLong mounting medium (Component B) to one brown vial of 
Prolong antifade reagent (Component A).  (Mix well by pipetting or vortexing, 
remove bubbles that have formed during the mixing procedure by sonication) 
15. Use the slide separator to remove the chamber.  Put the slides on the metal slide 
holder for the following wash. 
16. Wash chamber slide with PBS 3 x.   
17. Incubate chamber slide in 70% ethanol 1 x. 
18. Incubate chamber slide in 95% ethanol 1 x. 
19. Incubate chamber slide in 100% ethanol 1 x. 
20. Incubate chamber slide in fresh xylene 1 x. 
21. Apply a small amount of antifade reagent/mounting medium mixture to the chamber 
slide, cover the slide while it is still wet.  (Use glass rod to put a line of medium on 
the side of the coverglass, then cover the slide at 45° angle to avoid bubbles) use 
razor blasé to help coverslipping. 
22. Place the coverglass/slide on a flat surface in the dark to dry overnight at RT. 
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23. Once dry, seal the coverglass to the slide with fingernail polish, to prevent shrinkage 
of the mounting medium and subsequent sample distortion.   
24. After sealing, store the coverglass/slide upright in a covered slide box at -20°C.  
Desiccant may be added to the box to ensure that the slide remains dry. 
25. Examine sample under Fluorescence microscopy. 
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APPENDIX D 
PROTOCOL: ELISA APOPTOSIS ASSAY 
 
Purpose:  To determine the amount of apoptotic cells 
 
Materials: 
ELISA kit: Cell death detection ELISA Plus from Roche- (BM# 1774425) 
Reconstitute working solutions (refer to manual, pg 7) 
Bottle 1: anti-histone-biotin: each bottle, reconstitute in 450 μL double distilled 
H2O for 10 min and mix well (store at 2-8°C up to 2 months) 
Bottle 2: anti-DNA-POD- reconstitute with 450 μL double distilled H2O for 10 
min and mix well (store at 2-8°C upto 2 months) 
Bottle 3: Positive control - reconstitute with 450 μL double distilled H2O for 10 
min and mix well (store at 2-8°C upto 2 months) 
Bottle 7: ABTS Tablets- dissolve 1 tablet in 5 ml of substrate buffer (vial 6). 
(100 μL / sample). This is light sensitive and hence store container in a foil wrap 
(store for 1 month protected form light) 
Complete RPMI media (without γ- INF) 
Label 3 sets of 2 ml or 1.7 ml eppys (depending on the volume in the plate): 
floaters collection (step 1), supernatant collection (step 11) and counting.  
Procedure: 
 
1. Under sterile conditions in the hood: swirl the 35 mm dish and collect the media 
and floating cells into the 1st set of 2 ml eppy-tubes.  
 
2. Add 1ml of sterile PBS into the plates and put them in the 33oC incubator for 
counting later.  
 
3. Centrifuge the first set of eppy-tubes in the Eppendorf centrifuge at 5,000 rpm 
for 5 min at RT.  
 
4. Remove supernatant using 1ml pipette manually without disturbing the pellet 
(pellet is imaginary most of the time).  
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5. Resuspend pellet in 1ml media without γ-IFN.  
 
6. Finger flick the tubes to mix. 
 
7. Centrifuge again at 5,000 rpm for 5 min at RT to wash and remove the excess 
media. 
 
8. Remove as much of the supernatant as possible (without disturbing the pellet) 
and discard it. 
 
9. Resuspend cell pellet with 125 μL lysis buffer (bottle 5 of Cell death detection 
ELISA kit) 
 
10. Mix thoroughly and incubate sample for 30 min at 4°C (cell culture fridge)  
 
11. During incubation, prepare the immunoreagent (manual: pg 9) 
 
For 10 tests- 40 μL of reconstituent from bottle 1 +  40 μL of reconstituent from 
bottle 2 + 720 μL of incubation buffer from bottle 4. Mix well.  
 
 
12. After incubation, centrifuge lysate at max speed (13,600 x g, eppendorf 
centrifuge) for 10 min, at 4°C. (Pellets out the intact cells and nuclei etc leaving 
the cytosolic fraction in the supernatant for the assay)  
 
13. Transfer 100 μL of the supernatant carefully into another eppy-tube without 
shaking the pellet. Keep tubes on ice. 
 
Continue in the main lab 
 
14. Transfer 20μL of all samples into MP. Pipette into the middle of the MP well. 
 
15. Use 20μL of 
♦ Well (A –1) – Background (Bottle 4 of kit) 
♦ Well (B-1) – Blank (ABTS solution - Tablet dissolved in substrate- 
reconstituted tablet) 
♦ Well (C-1) – Positive control (Bottle 3 of kit) 
 
 
16. Add to each well 80μL of the immunoreagent using multiple channel pipette/ 
regular (no immuno-reagent into the blank (B-1) 
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17. Remove all bubbles from the wells in the MP with a pipette tip. 
 
18. Cover the MP with an adhesive cover and foil. Incubate on a MP shaker under 
gently shaking (300 rpm) for 2hr at 15-25°C. 
 
19. Empty the solution from the MP thoroughly by tapping (tape both sides of the 
modules to secure them).  
 
20. Rinse each well 3x with 250μL of incubation buffer (bottle 4).  
 
21. Empty the solution carefully by tapping. 
 
22. In the dark, pipette to each well 100μL ABTS solution (light sensitive). 
 
23. Incubate on a plate shaker at 250 rpm in the cold room until the color 
development is sufficient for a photometric analysis (approx 2-5min). Check 
every minute. 
 
24. Measure at 405nm against ABTS solution as a blank (reference wavelength 
approx 490nm) 
 
 
Counting: 
 
26. Remove the plates from the incubator 
27. Swirl the plates with the PBS and aspirate the PBS from the plates 
28. Add 0.5 ml Trypsin and put them in the incubator for 3 minutes @ 330C.  
29. Add 1ml media into each of the plates with the trypsin. 
30. Swirl the plate and collect all the cell/ trypsin and media into the eppy-tubes. 
31. Count the cells using hemocytometer.  
32. Calculate the cell density and total number of adherent cells.  
33. Use this count to calculate the apoptotic index. 
a. Apoptotic Index = Optical Density/ # adherent cells 
34. Plot and analyze data using super-ANOVA 
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APPENDIX E 
SEQUENCE OF UNUSED BCL-2 CONSTRUCTS 
 
The first 654 nucleotides (218 amino acids) are the same in all three constructs.  They all 
have the same differences in those first nucleotides from the sequence given by BLAST.  
Below is the remaining nucleotide and amino acid sequence for the organelle specific 
plasmids. 
 
ER-targeted 
Nucleotide sequence: 
ATC ACT ACC GTT GAA TCG AAC TCT AGT TGG TGG ACT ACT GGG TTA TCC CTG CGT 
CTC TGC TCT GGT TTA AGC CCT GAT GTA CCG TCT GTA CAT GCT GAA GAT AAT 
 
 
Amino acid sequence: 
 
ITTVESNSSWWTTGLSLRLCSGLSPDVPSVHAEDN 
 
 
Mitochondrial-targeted 
Nucleotide sequence: 
CTG ATT CTC GCC ATG CTG GCA ATT GGG GTG TTC TCC CTC GGC GCC TTC ATT AGA 
TCA TTC AGC TCC GGA AGA ACA ATT GAT 
 
Amino acid sequence: 
LILAMLAIGVFSLGAFIRSFSSGRTID 
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